Lodde, Valentina;
Luciano, Alberto Maria;
Musmeci, Giulia;
Miclea, Ileana;
Tessaro, Irene;
Aru, Mariella;
Albertini, David F.;
Franciosi, Federica
A Nuclear and Cytoplasmic Characterization of Bovine Oocytes Reveals That Cysteamine Partially Rescues the Embryo Development in a Model of Low Ovarian Reserve
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
A Nuclear and Cytoplasmic Characterization of Bovine Oocytes Reveals That Cysteamine Partially Rescues the Embryo Development in a Model of Low Ovarian Reserve
Contributor:
Lodde, Valentina;
Luciano, Alberto Maria;
Musmeci, Giulia;
Miclea, Ileana;
Tessaro, Irene;
Aru, Mariella;
Albertini, David F.;
Franciosi, Federica
Published:
MDPI AG, 2021
Published in:
Animals, 11 (2021) 7, Seite 1936
Language:
English
DOI:
10.3390/ani11071936
ISSN:
2076-2615
Origination:
Footnote:
Description:
Decreased oocyte quality is a major determinant of age-associated fertility decline. Similarly, individuals affected by early ovarian aging carry low-quality oocytes. Using an established bovine model of early ovarian aging, we investigated key features of ‘quality’ oocyte maturation, associated with the onset of egg aneuploidy and reproductive aging, such as histone modifications, mitochondria distribution and activity, reduced glutathione (GSH) content, and gap junction functionality. Bovine ovaries were classified according to the antral follicle count (AFC), and the retrieved oocytes were processed immediately or matured in vitro. We observed alterations in several cellular processes, suggesting a multifactorial etiology of the reduced oocyte quality. Furthermore, we performed a rescue experiment for one of the parameters considered. By adding cysteamine to the maturation medium, we experimentally increased the free radical scavenger ability of the ‘low competence’ oocytes and obtained a higher embryo development. Our findings show that adopting culture conditions that counteract the free radicals has a positive impact on the quality of ‘compromised’ oocytes. Specifically, cysteamine treatment seems to be a promising option for treating aging-related deficiencies in embryo development.